AI assistant
ACRUX LIMITED — Call Transcript 2016
Aug 3, 2016
64293_rns_2016-08-03_886b718f-934a-4488-abfc-df4c27c25856.pdf
Call Transcript
Open in viewerOpens in your device viewer
ACRUX (ACR) - ASX ANNOUNCEMENT
4 AUGUST 2016
2016 ANNUAL RESULTS - INVESTOR CONFERENCE CALL
==> picture [489 x 13] intentionally omitted <==
Acrux (ASX: ACR) today confirms that it will host an Investor Conference Call to discuss the results for the year ended 30 June 2016.
Investor Conference Call details: Date: Wednesday 10 August 2016 Time: 11am (Australian Eastern Standard Time) Conference ID: 548 892
Dial-in Details: Toll Free Dial-in Details: 1800 558 698 Australia: +61 2 9007 3187 New Zealand 0800 453 055 Singapore 800 101 2785 United States 1855 8811 339 United Kingdom 0800 051 8245
A Q&A session will be held following the Company presentation. Shareholders are encouraged to participate by forwarding questions to [email protected] in advance of the Conference Call.
Acrux recommends participants dial in at least 5 to 10 minutes prior to the commencement of the call. A recording of the call will be made available in the ‘Investor Centre’ section of the Company website at: http://www.acrux.com.au
For further information, contact
Michael Kotsanis, CEO and Managing Director: 03 8379 0100 Sharon Papworth, CFO and Company Secretary: 03 8379 0100
About Acrux
Acrux (ASX: ACR) is a drug development company focused on commercialising topical products using its proprietary drug delivery technology. Incorporated in 1998 and using in house facilities and capabilities, Acrux has successfully developed and licensed a number of pharmaceutical products in the US and Europe using the Patchless Patch[TM] , a fast-drying and invisible topical application technology. Acrux will continue to innovate and bring its developed products to the market in collaboration with licensees.
For further information on Acrux, visit www.acrux.com.au
==> picture [541 x 82] intentionally omitted <==